A Phase II Trial of TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Carcinoma of the Lung
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2018
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 14 Dec 2017 Planned number of patients changed from 30 to 34.
- 30 Jun 2017 Planned End Date changed from 30 Jun 2021 to 30 Jul 2021.
- 30 Jun 2017 Planned primary completion date changed from 30 Jun 2020 to 30 Jul 2020.